{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:55:17Z","timestamp":1790286917149,"version":"4.1.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1097\/dad.0000000000000230","type":"journal-article","created":{"date-parts":[[2015,2,20]],"date-time":"2015-02-20T18:47:27Z","timestamp":1424458047000},"page":"e96-e99","source":"Crossref","is-referenced-by-count":19,"title":["Panniculitis With Necrotizing Granulomata in a Patient on BRAF Inhibitor (Dabrafenib) Therapy for Metastatic Melanoma"],"prefix":"10.1097","volume":"37","author":[{"given":"Nisha S.","family":"Ramani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan L.","family":"Curry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Kapil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald P.","family":"Rapini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Tetzlaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor G.","family":"Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Torres-Cabala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20-20210202","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/humu.20802","article-title":"Sunlight ultraviolet irradiation and BRAF V600 mutagenesis in human melanoma.","volume":"29","author":"Besaratinia","year":"2008","journal-title":"Hum Mutat"},{"key":"R2-20-20210202","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1038\/bjc.2013.622","article-title":". Mutation landscape in melanoma patients clinical implications of heterogeneity of BRAF mutations.","volume":"109","author":"Heinzerling","year":"2013","journal-title":"Br J Cancer"},{"key":"R3-20-20210202","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":". Improved survival with vemurafenib in melanoma with BRAF V600E mutation.","volume":"364","author":"Chapman","year":"2011","journal-title":"N Engl J Med"},{"key":"R4-20-20210202","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.clinthera.2012.06.009","article-title":"Vemurafenib in patients with BRAF V600E mutation-positive advanced melanoma.","volume":"34","author":"Ravnan","year":"2012","journal-title":"Clin Ther"},{"key":"R5-20-20210202","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jaad.2012.04.008","article-title":". Diverse cutaneous side effects associated with BRAF inhibitor therapy: a clinicopathologic study.","volume":"67","author":"Chu","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"R6-20-20210202","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/annonc\/mdt015","article-title":". Prospective study of cutaneous side-effects associated with the BRAF inhibitor vemurafenib: a study of 42 patients.","volume":"24","author":"Boussemart","year":"2013","journal-title":"Ann Oncol"},{"key":"R7-20-20210202","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1001\/archdermatol.2012.125","article-title":". Cutaneous toxic effects associated with vemurafenib and inhibition of the BRAF pathway.","volume":"148","author":"Huang","year":"2012","journal-title":"Arch Dermatol"},{"key":"R8-20-20210202","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/DAD.0000000000000023","article-title":". Panniculitis in patients treated with BRAF inhibitors: a case series.","volume":"36","author":"Choy","year":"2014","journal-title":"Am J Dermatopathol"},{"key":"R9-20-20210202","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5070\/D370X41670","article-title":". Vemurafenib-associated neutrophilic panniculitis: an emergent adverse effect of variable severity.","volume":"19","author":"Maldonado-Seral","year":"2013","journal-title":"Dermatol Online J"},{"key":"R10-20-20210202","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/CMR.0b013e3283570792","article-title":". Vemurafenib-induced neutrophilic panniculitis.","volume":"22","author":"Monfort","year":"2012","journal-title":"Melanoma Res"},{"key":"R11-20-20210202","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1001\/archdermatol.2011.2842","article-title":". Panniculitis with arthralgia in patients with melanoma treated with selective BRAF inhibitors and its management.","volume":"148","author":"Zimmer","year":"2012","journal-title":"Arch Dermatol"},{"key":"R12-20-20210202","doi-asserted-by":"crossref","first-page":"e320","DOI":"10.1200\/JCO.2012.45.8307","article-title":". Erythema nodosum-like panniculitis in patients with melanoma treated with vemurafenib.","volume":"31","author":"Sinha","year":"2013","journal-title":"J Clin Oncol"},{"key":"R13-20-20210202","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/cup.12149","article-title":"Neutrophilic panniculitis developing after treatment of metastatic melanoma with vemurafenib.","volume":"40","author":"Kim","year":"2013","journal-title":"J Cutan Pathol"},{"key":"R14-20-20210202","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1056\/NEJMoa1112302","article-title":". Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib.","volume":"366","author":"Sosman","year":"2012","journal-title":"N Engl J Med"},{"key":"R15-20-20210202","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1056\/NEJMc053425","article-title":"Panniculitis during dasatinib therapy for imatinib-resistant chronic myelogenous leukemia.","volume":"354","author":"Assouline","year":"2006","journal-title":"N Engl J Med"},{"key":"R16-20-20210202","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1046\/j.1525-1470.2001.01969.x","article-title":"Neutrophilic dermatoses in two children with idiopathic neutropenia: association with granulocyte colony-stimulating factor (G-CSF) therapy.","volume":"18","author":"Prendiville","year":"2001","journal-title":"Pediatr Dermatol"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000000230","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,6]],"date-time":"2023-08-06T17:15:51Z","timestamp":1691342151000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000372-201508000-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000000230","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}